The level of residual disease based on mutant NPM1 is an independent prognostic factor for relapse and survival in AML.
| Image |  |
|---|---|
| Description | scientific article published on 8 May 2013 |
| Author/s |
author: Study Alliance Leukemia (SAL) Nona Shayegi Caroline Heiderich Johannes Schetelig Christian Thiede Christoph Röllig Uwe Platzbecker Martin Bornhäuser Gerhard Ehninger Markus Schaich |
| Publication date | May 8, 2013 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |